Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,360 | 19,300 | 12,880 | 12,020 | 7,640 |
| Marketable Securities | 200 | 4,310 | 7,910 | 11,170 | 11,990 |
| Receivables | 8,710 | 8,360 | 7,820 | 8,040 | 8,770 |
| Inventories | 10,660 | 10,110 | 10,810 | 11,210 | 13,100 |
| Other current assets | 720 | 720 | 690 | 720 | 1,360 |
| TOTAL | $43,650 | $42,800 | $40,110 | $43,160 | $42,860 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 19,480 | 13,730 | 14,280 | 14,230 | 13,740 |
| TOTAL | $19,480 | $13,730 | $14,280 | $14,230 | $13,740 |
| Total Assets | $73,690 | $66,250 | $63,970 | $66,800 | $66,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 1,500 |
| Accounts payable and accrued liabilities | 1,710 | 990 | 1,330 | 1,730 | 2,390 |
| Accrued Expenses | 5,480 | 5,540 | 5,450 | 7,900 | 7,200 |
| Other current liabilities | 4,370 | 5,360 | 1,650 | 0 | 0 |
| TOTAL | $16,370 | $14,790 | $11,020 | $11,990 | $11,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,200 | 7,620 | 8,250 | 8,870 | 9,500 |
| Other Non-Current Liabilities | 800 | 790 | 400 | 420 | 440 |
| TOTAL | $13,820 | $13,450 | $16,380 | $16,590 | $13,170 |
| Total Liabilities | $30,210 | $28,260 | $27,410 | $28,600 | $24,930 |
| Shareholders' Equity | |||||
| Common Shares | 160 | 160 | 150 | 150 | 150 |
| Retained earnings | -95,360 | -94,300 | -93,630 | -91,530 | -87,920 |
| Other shareholders' equity | -70 | -220 | -160 | -480 | -440 |
| TOTAL | $43,480 | $37,980 | $36,560 | $38,200 | $41,740 |
| Total Liabilities And Equity | $73,690 | $66,240 | $63,970 | $66,800 | $66,670 |